Addex Therapeutics Ltd Diluted Earnings Loss Per Share From Continuing Operations
Addex Therapeutics Ltd (ADXN) reported Diluted Earnings Loss Per Share From Continuing Operations of -0.02 CHF/shares for the 3-month period ending 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations · last filed 2025-09-30
- Addex Therapeutics Ltd diluted earnings loss per share from continuing operations for the quarter ending 2025-06-30 was -0.02 CHF/shares.
- Addex Therapeutics Ltd diluted earnings loss per share from continuing operations for the quarter ending 2024-06-30 was -0.01 CHF/shares.
| Period end | Diluted Earnings Loss Per Share From Continuing Operations 3 month | Diluted Earnings Loss Per Share From Continuing Operations 6 month | Diluted Earnings Loss Per Share From Continuing Operations 12 month |
|---|---|---|---|
| 2025-06-30 | -0.02 CHF/shares 6-K · filed 2025-09-30 | -0.03 CHF/shares 6-K · filed 2025-09-30 | |
| 2024-12-31 | -0.05 CHF/shares 20-F · filed 2025-05-15 | ||
| 2024-06-30 | -0.01 CHF/shares 6-K · filed 2025-09-30 | -0.02 CHF/shares 6-K · filed 2025-09-30 | |
| 2023-12-31 | -0.03 CHF/shares 20-F · filed 2025-05-15 | ||
| 2022-12-31 | -0.24 CHF/shares 20-F · filed 2025-05-15 |